{"changeSha256":"e38acd736b5b5146c48a0bb043794267e2de170a23b3690bc1380ef1ab14d642","changedAt":"2026-07-27","changedFields":[{"after":"A long-acting amylin analogue under study. This profile cites a recruiting ClinicalTrials.gov record.","before":"A long-acting amylin analogue represented in ongoing ClinicalTrials.gov records.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/cagrilintide/versions/2/","version":2},"id":"profile:cagrilintide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.","peptideSlugs":["cagrilintide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/cagrilintide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-nct07253285-v5","name":"ClinicalTrials.gov","sourceClass":"A","title":"Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17","url":"https://clinicaltrials.gov/study/NCT07253285?a=5&tab=history","verifiedAt":"2026-07-22"}],"subject":{"slug":"cagrilintide","type":"profile"}}